Cargando…
ENDORSE: a prognostic model for endocrine therapy in estrogen‐receptor‐positive breast cancers
Advanced and metastatic estrogen receptor‐positive (ER(+)) breast cancers are often endocrine resistant. However, endocrine therapy remains the primary treatment for all advanced ER(+) breast cancers. Treatment options that may benefit resistant cancers, such as add‐on drugs that target resistance p...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9172932/ https://www.ncbi.nlm.nih.gov/pubmed/35671075 http://dx.doi.org/10.15252/msb.202110558 |